Follow this preprint
SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan
View ORCID ProfileJing Yu, View ORCID ProfileWen Ouyang, View ORCID ProfileMelvin L.K. Chua, View ORCID ProfileConghua Xie
doi: https://doi.org/10.1101/2020.02.22.20025320
Now published in JAMA Oncology doi: 10.1001/jamaoncol.2020.0980
Jing Yu
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China, 430071
2Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China, 430071
3Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China, 430071
MDWen Ouyang
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China, 430071
2Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China, 430071
3Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China, 430071
MDMelvin L.K. Chua
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China, 430071
4Division of Radiation Oncology, Division of Medical Sciences, National Cancer Centre Singapore
5Oncology Academic Programme, Duke-NUS Medical School,Singapore
MBBS FRCR PhDConghua Xie
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China, 430071
2Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China, 430071
3Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China, 430071
MD
Data Availability
Clinical details on the cancer history and COVID-19 pneumonia are summarized in Table 1. The further details of the current study are available from the corresponding author upon reasonable request.
Posted February 25, 2020.
SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan
Jing Yu, Wen Ouyang, Melvin L.K. Chua, Conghua Xie
medRxiv 2020.02.22.20025320; doi: https://doi.org/10.1101/2020.02.22.20025320
Now published in JAMA Oncology doi: 10.1001/jamaoncol.2020.0980
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (419)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3195)
- Dermatology (270)
- Emergency Medicine (474)
- Epidemiology (13187)
- Forensic Medicine (19)
- Gastroenterology (883)
- Genetic and Genomic Medicine (5015)
- Geriatric Medicine (467)
- Health Economics (767)
- Health Informatics (3159)
- Health Policy (1119)
- Hematology (418)
- HIV/AIDS (992)
- Medical Education (466)
- Medical Ethics (124)
- Nephrology (512)
- Neurology (4765)
- Nursing (253)
- Nutrition (706)
- Oncology (2454)
- Ophthalmology (697)
- Orthopedics (275)
- Otolaryngology (335)
- Pain Medicine (317)
- Palliative Medicine (89)
- Pathology (527)
- Pediatrics (1271)
- Primary Care Research (542)
- Public and Global Health (7326)
- Radiology and Imaging (1651)
- Respiratory Medicine (959)
- Rheumatology (469)
- Sports Medicine (413)
- Surgery (531)
- Toxicology (68)
- Transplantation (227)
- Urology (197)